Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort st...
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
The high cost of fidaxomicin has restricted its use despite the benefit of a lower
Clostridioides difficile
infection (CDI) recurrence rate at 4 weeks of follow-up. This short follow-up represents the main limitation of pivotal clinical trials of fidaxomicin, and some recent studies question its benefits over vancomycin. Moreover, the main ri...
Alternative Titles
Full title
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2533056491
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2533056491
Other Identifiers
ISSN
0300-8126,1439-0973
E-ISSN
1439-0973
DOI
10.1007/s15010-020-01567-5
